- Home
- MKTW vs TRIB Comparison
MKTW vs TRIB Comparison
Compare MKTW & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- TRIB
- Stock Information
- Founded
- MKTW 1999
- TRIB 1992
- Country
- MKTW United States
- TRIB Ireland
- Employees
- MKTW N/A
- TRIB N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MKTW Technology
- TRIB Health Care
- Exchange
- MKTW Nasdaq
- TRIB Nasdaq
- Market Cap
- MKTW 22.2M
- TRIB 24.0M
- IPO Year
- MKTW N/A
- TRIB N/A
- Fundamental
- Price
- MKTW $0.51
- TRIB $0.81
- Analyst Decision
- MKTW Hold
- TRIB
- Analyst Count
- MKTW 1
- TRIB 0
- Target Price
- MKTW $2.00
- TRIB N/A
- AVG Volume (30 Days)
- MKTW 276.3K
- TRIB 147.6K
- Earning Date
- MKTW 11-07-2024
- TRIB 11-15-2024
- Dividend Yield
- MKTW 7.85%
- TRIB N/A
- EPS Growth
- MKTW N/A
- TRIB N/A
- EPS
- MKTW 0.13
- TRIB N/A
- Revenue
- MKTW $423,378,000.00
- TRIB $59,126,000.00
- Revenue This Year
- MKTW N/A
- TRIB $11.63
- Revenue Next Year
- MKTW N/A
- TRIB $10.13
- P/E Ratio
- MKTW $3.92
- TRIB N/A
- Revenue Growth
- MKTW N/A
- TRIB N/A
- 52 Week Low
- MKTW $0.47
- TRIB $0.75
- 52 Week High
- MKTW $3.17
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- MKTW 42.90
- TRIB 25.82
- Support Level
- MKTW $0.50
- TRIB $0.75
- Resistance Level
- MKTW $0.53
- TRIB $0.93
- Average True Range (ATR)
- MKTW 0.04
- TRIB 0.11
- MACD
- MKTW 0.00
- TRIB 0.00
- Stochastic Oscillator
- MKTW 22.41
- TRIB 13.00
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.